Lab News
U.K. vitamin D study feeds into global debates on appropriate use
December 5, 2019 -- Prescriptions for vitamin D to U.K. children have risen dramatically over the years, and medical records suggest inappropriate use, according to a study published online December 3 in BMJ Open. The results feed into international debates about overuse and the high costs of supplementation and testing. Read More
FDA clears Roche's novel MRSA nasal swab test
December 5, 2019 -- The U.S. Food and Drug Administration (FDA) has given the green light to Roche Molecular Systems to market a new test based on bacterial viability and novel technology for detecting methicillin-resistant Staphylococcus aureus (MRSA) bacterial colonization, a common cause of hospital-acquired infections. Read More
Philips, Paige join forces on AI and digital pathology
December 5, 2019 -- Philips Healthcare and Paige are joining to deliver artificial intelligence (AI) applications for cancer to pathology laboratories. Read More
Nanomix mobile, 3-in-1 sepsis test gets CE Mark
December 5, 2019 -- Nanomix announced that its S1 assay for serious infections, including sepsis and bacteremia, has received the CE Mark, paving the way for sales in European markets in 2020. Read More
High cost rules out NIPT as 1st test for Down syndrome
December 4, 2019 -- Noninvasive prenatal testing (NIPT) is better than conventional testing for Down syndrome, but its high cost must come down to make it more viable as a first-tier screening test, according to a Canadian study published on December 4 in PLOS One. Read More
FDA clears FoundationOne CDx for Piqray in breast cancer
December 4, 2019 -- The U.S. Food and Drug Administration (FDA) has approved Foundation Medicine's FoundationOne CDx broad companion diagnostic for use in profiling patients with metastatic breast cancer and helping to select those who will respond to treatment with the targeted drug alpelisib (Piqray). Read More
Veracyte licenses NanoString diagnostic platform in $50M deal
December 4, 2019 -- Veracyte is set to pay $50 million -- $40 million in cash and the rest in common stock -- for an exclusive global license to the NanoString nCounter diagnostics platform. The company said the deal will power the international expansion of its genomics products, especially its investigational nasal swab test for lung cancer. Read More
FDA awards $20M to DNAnexus to enhance cloud-based research portal
December 4, 2019 -- The U.S. Food and Drug Administration (FDA) has awarded a five-year, $20 million contract to DNAnexus to build on its precisionFDA research and development cloud-based portal, which enables collaboration in validating next-generation sequencing technologies. Read More
SiO2 launches unbreakable blood collection tube for genetic diagnostics
December 4, 2019 -- SiO2 Materials Science announced the launch of its unbreakable Synergy blood collection tube for use in genetic diagnostics. Read More
Prostate cancer urine test adapted for home sampling
December 3, 2019 -- The investigational prostate urine risk classifier is feasible for use with the collection of samples at home, according to a recent study by U.K. researchers. Read More
Diagnostic Pathology Update (DPU)
December 5-10
Playa Herradura, Puntarenas Costa Rica
American Society of Hematology (ASH) Annual Meeting
December 11-14
Atlanta, Georgia United States
LabPulse on LinkedIn
LabPulse on Facebook
LabPulse on Twitter
Latest Tweets